Vote Scores

Home / Companies / TG Therapeutics, Inc. / 14 Jun 2024

Meeting · year to 30 June 2024324 filers reporting

TG Therapeutics, Inc.: meeting of 14 Jun 2024

Votes reported on Form N-PX, item by item

324 Form N-PX filers reported votes at the TG Therapeutics, Inc. meeting of 14 Jun 2024. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.

foragainstabstain, withhold or otheramber tick: the portion cast against management

Items

1

DIRECTOR ELECTIONSIssuer

Director elections

6 nominees; 29.3% of reported votes for; 82 filers withheld from or voted against at least one nominee.

986 vote records from 93 filers. 65 of the 93 filers that marked the item either way voted against management.

20.4% for0.0% against79.6% other69.9% against management93 filers
2

SECTION 14A SAY-ON-PAY VOTESIssuer

Advisory vote on executive pay (say-on-pay)

444 vote records from 321 filers. 216 of the 308 filers that marked the item either way voted against management. 13 filers reported this item without a management mark.

26.2% for68.2% against5.6% other70.1% against management321 filers38.3% for58.5% against3.1% other61.5% against management59,868,382 reported shares
3

AUDIT-RELATEDIssuer

Audit-related items (auditor ratification)

166 vote records from 93 filers. 1 of the 93 filers that marked the item either way voted against management.

98.9% for0.0% against1.1% other1.1% against management93 filers99.9% for0.0% against0.1% other0.1% against management24,821,155 reported shares
4

CAPITAL STRUCTUREIssuer

CAPITAL STRUCTURE: management items

Management items in this category are shown together; filers word and number them differently.

166 vote records from 93 filers. 41 of the 93 filers that marked the item either way voted against management.

55.9% for44.1% against44.1% against management93 filers90.3% for9.7% against9.5% against management24,821,155 reported shares, counted once per item in this group
5

COMPENSATIONIssuer

COMPENSATION: management items

Management items in this category are shown together; filers word and number them differently.

170 vote records from 96 filers. 3 of the 96 filers that marked the item either way voted against management.

96.9% for2.1% against1.0% other3.1% against management96 filers99.9% for0.1% against0.1% other0.1% against management24,831,277 reported shares, counted once per item in this group

How the largest families voted

Family1. Directors2. Say-on-pay3. Auditor
VanguardForForFor
BlackRock and iSharesAbstain or withhold *Against *For
FidelityForAgainst *For
DimensionalNo reportAgainst *No report
State Street and SPDRAbstain or withhold *ForFor
Franklin TempletonAbstain or withhold *Against *For
InvescoForAgainst *For
EquitableAbstain or withhold *Against *For
Charles SchwabAbstain or withhold *Against *For
Nuveen and TIAAAbstain or withhold *Against *For
ProShares and ProFundsAbstain or withhold *Against *For
John Hancock and ManulifeAbstain or withhold *Against *For
Morgan Stanley, Eaton Vance and CalvertAbstain or withhold *Against *For
J.P. MorganAbstain or withhold *Against *For
Goldman SachsAbstain or withhold *Against *For
PGIM and PrudentialNo reportAgainst *No report
Northern Trust and FlexSharesForAgainst *For
SEIAbstain or withhold *Against *For
T. Rowe PriceAbstain or withhold *Against *For
Lincoln FinancialAbstain or withholdForFor
VoyaForAgainst *For
First TrustAbstain or withhold *Against *For
Russell InvestmentsAbstain or withhold *Against *For
NationwideAbstain or withhold *Against *For
Victory CapitalAbstain or withhold *Against *For
Brighthouse FundsAbstain or withhold *Against *For
Guggenheim and RydexAbstain or withhold *Against *For
Columbia ThreadneedleNo reportAgainst *No report
BNY MellonAbstain or withhold *Against *For
PrincipalAbstain or withhold *Against *For
Pacific Life fundsAbstain or withhold *Against *For
Global XAbstain or withhold *Against *For
AllianceBernsteinNo reportAgainst *No report
DWSAbstain or withhold *Against *For
Janus HendersonNo reportAgainst *No report
Neuberger BermanNo reportAgainst *No report
BairdNo reportAgainst *No report

* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.

Questions

How did large funds vote at the TG Therapeutics, Inc. meeting?

324 Form N-PX filers reported votes at the meeting of 14 Jun 2024. On say-on-pay, 216 of 308 voted against management (70.1%). The family table lists each of the largest families item by item.

Is this the meeting result?

No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by TG Therapeutics, Inc. on Form 8-K.

Why are director elections shown as counts only?

Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.

Every meeting on file for TG Therapeutics, Inc.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing TG Therapeutics, Inc. with a meeting date within three days of 14 Jun 2024. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.